18002022232

Consultation Timings

SunAct - Thane

Doctor Name Days Timings
Dr. Bilal Kazi Mon to Sat 9:30 am – 5:00 pm
Dr. Naveen Vairamoorthy Mon to Sat 9:00 am – 4:00 pm
Dr. (Prof.) Vijay Patil Tues & Thurs 8:30 am – 11:00 am

SunAct - Khar

Doctor Name Days Timings
Dr. Mamta Manglani Mon / Wed / Thurs 11:00 am – 1:00 pm
Dr. Amit Jain Mon / Wed / Thurs 2:00 pm – 4:00 pm
Dr. Sneha Shinde Mon to Fri 9:00 am – 5:00 pm
Dr. Kritika Mehrotra Mon / Wed / Fri 1:00 pm – 3:00 pm
Tues / Thurs / Sat 1:00 pm – 2:00 pm

Meet Our Doctors

Explore doctor profiles before booking your appointment.

Book an Appointment

Share your details below, and we’ll reach out to you without delay

Share your details below, and we’ll reach out to you without delay.

Disclaimer : We will be using this information for calling purposes only.

Share your details below, and we’ll reach out to you without delay.

Disclaimer : We will be using this information for calling purposes only.

SunAct genitourinary cancer case study on GPC3-targeted CAR T therapy for refractory non-seminomatous germ cell tumor
SunAct genitourinary cancer case study on GPC3-targeted CAR T therapy for refractory non-seminomatous germ cell tumor
SunAct colon cancer case study highlighting TCR-based approach in metastatic colon cancer with lung lesions
SunAct colon cancer case study highlighting TCR-based approach in metastatic colon cancer with lung lesions
SunAct breast cancer case study showcasing HER2-positive treatment with CAR T-cell therapy
SunAct breast cancer case study showcasing HER2-positive treatment with CAR T-cell therapy
SunAct head and neck cancer case study using TCR-p53 therapy in inoperable squamous cell carcinoma
SunAct case study featuring gamma delta T-cell therapy for recurrent tongue carcinoma with extensive metastasis
SunAct case study featuring gamma delta T-cell therapy for recurrent tongue carcinoma with extensive metastasis
SunAct head and neck cancer case study on salivary ductal carcinoma managed with advanced therapies
SunAct head and neck cancer case study on salivary ductal carcinoma managed with advanced therapies
SunAct case study on GD2-targeted CAR T therapy for diffuse midline glioma in a 22-year-old male
SunAct case study on GD2-targeted CAR T therapy for diffuse midline glioma in a 22-year-old male
SunAct CNS case study on GBM treatment using multiple gene mutation targeting in a 36-year-old male
SunAct CNS case study on GBM treatment using multiple gene mutation targeting in a 36-year-old male